TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

7.40$ -1.1% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Immatics NV (IMTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 486 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMTX
Line item Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – – 34 34 34 134 122 108 283 255 238 217 199 175 282 368 354 408 378 410 437 510 653 627 577 696 642 567 519 562 544 486
– – – – 52 31 31 124 110 92 267 239 222 198 180 152 260 336 322 377 345 365 385 449 588 559 513 630 574 504 458 504 485 429
– – – – -52 26 26 103 72 86 234 208 195 160 161 133 247 265 178 149 118 130 83 218 122 158 189 237 243 257 335 346 302 232
– – – – 52 30 30 119 105 86 259 232 217 193 173 145 253 324 309 362 330 348 366 426 564 531 491 604 544 478 431 469 454 393
– – – – 0.7 0.7 0.7 2.7 0.3 2.3 2.4 2.9 2.2 2.7 3.2 2.4 0.7 1.0 2.0 1.1 1.2 1.9 1.4 5.7 3.4 3.6 8.4 6.7 6.6 2.9 4.3 6.9 4.8 6.7
– – – – -1.2 – – 1.2 0.0 1.4 3.4 3.3 2.3 1.8 2.7 3.8 3.5 6.6 8.9 0.0 10 9.5 11 11 0.0 0.0 – – – – – – – –
– – – – – – – – 9.9 14 15 14 14 16 17 20 20 26 26 26 30 42 – – – – – – – – – – – –
– – – – 0.3 0.3 0.3 1.0 1.0 1.0 1.0 0.9 0.9 1.3 1.3 1.3 1.3 1.3 1.5 1.6 1.6 1.7 1.6 1.5 1.5 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6
– – – – 44 44 44 175 172 176 161 167 144 140 164 151 166 243 241 195 178 192 190 292 252 239 195 121 105 103 102 78 88 86
– – – – 17 17 17 69 77 88 76 77 68 73 107 95 92 114 124 106 101 124 121 157 149 150 129 68 56 57 62 43 55 57
– – – – – – – 1.4 1.5 1.9 1.9 1.9 2.0 2.3 2.6 2.7 2.8 2.4 2.4 2.2 2.5 2.7 2.8 2.6 2.8 3.2 2.8 2.9 3.0 3.0 2.9 2.8 2.6 2.7
– – – – 1.2 1.2 1.2 4.9 8.7 8.1 9.7 2.6 10 9.4 12 3.0 13 13 13 4.0 4.7 5.5 6.2 7.7 6.1 3.8 8.9 10 5.9 4.2 2.8 0.3 8.1 6.2
– – – – -9.2 -10 -10 -42 -51 -68 122 87 94 76 35 24 116 125 113 213 200 218 248 218 401 388 383 575 537 465 417 484 456 399
– – – – -58 -58 -58 -233 -242 -263 -440 -444 -484 -508 -521 -538 -452 -466 -487 -500 -520 -545 -571 -605 -600 -618 -627 -590 -629 -700 -750 -786 -845 -906
63 63 63 63 63 63 63 63 33 1.2 63 63 63 63 63 63 63 65 66 75 77 77 83 85 106 103 110 107 122 122 122 126 135 137

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?